These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8220079)

  • 21. [Role of the diabetogenic factor in hypercoagulation of the blood].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Fiziol Zh SSSR Im I M Sechenova; 1986 Mar; 72(3):373-6. PubMed ID: 3709867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pancreas as a source of natural diabetogenic factor in alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1991; (2):46-7. PubMed ID: 1881712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Age-related characteristics of the manifestation of the diabetogenic factor in the blood of animals maintained on natural and atherogenic diets].
    Kudriashov BA; Ul'ianov AM; Bazaz'ian GG; Pytel' IuA
    Probl Endokrinol (Mosk); 1984; 30(2):65-70. PubMed ID: 6718336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental models of juvenile onset (insulin-dependent) diabetes mellitus.
    Craighead JE
    Monogr Pathol; 1980; 21():166-76. PubMed ID: 6261120
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental analysis of the pathophysiological significance of the "diabetogenic factor" present in the blood of animals with alloxan diabetes].
    Baskakova GM; Kudriashov BA; Pytel' IuA
    Probl Endokrinol (Mosk); 1981; 27(4):42-5. PubMed ID: 7027248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibrinolytic and hypoglycemic effects of the Pro-Gly-Pro-Leu peptide during development of insulin-dependent diabetes in rats].
    Liapina LA; Miasoedov NF; Andreeva LA; Ul'ianov AM; Obergan TIu; Shubina TA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2010; (3):375-9. PubMed ID: 20583622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 1 beta-mediated destruction of pancreatic beta-cells in vitro. A model of beta-cell destruction in insulin-dependent diabetes mellitus?
    Helqvist S
    Dan Med Bull; 1994 Apr; 41(2):151-66. PubMed ID: 8039431
    [No Abstract]   [Full Text] [Related]  

  • 28. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pathogenetic characteristics and the possible ways for the pharmacological correction of insulin-dependent diabetes mellitus].
    Chernov IuN; Pashkov AN; Vasin MV; Batishcheva GA; Zolotarev DV
    Eksp Klin Farmakol; 1999; 62(3):60-6. PubMed ID: 10439953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
    Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC
    Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes.
    Shertzer HG; Schneider SN; Kendig EL; Clegg DJ; D'Alessio DA; Genter MB
    Biochem Pharmacol; 2008 Mar; 75(6):1402-10. PubMed ID: 18237716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Free-radical theory of etiopathogenesis of insulin-dependent diabetes mellitus].
    Ciechanowski K; Machoy Z
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):48-50. PubMed ID: 1409043
    [No Abstract]   [Full Text] [Related]  

  • 36. [Feasibility of correction of insulin insufficiency after autotransplantation of splenic tissue in duodenopancreatectomy].
    Timerbulatov VM; Faiazov RR; Khasanov AG; Rakhmatullin SI; Timerbulatov ShV; Saiapov MM
    Khirurgiia (Mosk); 2006; (3):21-6. PubMed ID: 16710236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity of animal models of type 1 diabetes, and strategies to enhance their utility in translational research.
    Graham ML; Schuurman HJ
    Eur J Pharmacol; 2015 Jul; 759():221-30. PubMed ID: 25814249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vasoactive intestinal polypeptide(VIP)- and insulin-producing cells--molecular biology, physiology and pathology].
    Okamoto H
    Nihon Naibunpi Gakkai Zasshi; 1984 Dec; 60(12):1449-63. PubMed ID: 6099284
    [No Abstract]   [Full Text] [Related]  

  • 40. Early intervention in insulin-dependent diabetes mellitus.
    Cahill GF
    Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.